However, the frequent side effects and the carcinogenic potential of many cytoreductiveagents limit their use, especially in younger patients.
2
Studies of glutamine nutrition combined with current combinations of cytoreductiveagents and hematopoietic growth factors in BMT will be particularly pertinent.